```html

Physiologic Jaundice of the Newborn

What is Jaundice of newborn (physiologic)?

Physiologic jaundice is a common, usually harmless type of yellow discoloration of the skin and whites of the eyes (sclerae) that appears in many healthy newborns during the first week of life. It results from a temporary imbalance between the production and elimination of bilirubin, a yellow pigment formed when red blood cells break down. In most cases, the condition resolves spontaneously as the infant’s liver matures and becomes more efficient at processing bilirubin.

According to the American Academy of Pediatrics (AAP), physiologic jaundice affects up to 60 % of term infants and 80 % of pre‑term infants <sup>[1]</sup>. While the term “physiologic” indicates that the jaundice is expected and benign, careful monitoring is essential because high bilirubin levels can progress to kernicterus—a rare but permanent brain injury.

Common Causes

The bilirubin surge in physiologic jaundice is multifactorial. The most frequent contributors include:

• Increased red‑blood‑cell turnover: Newborns have a higher proportion of fetal hemoglobin, which breaks down faster than adult hemoglobin.
• Immature liver enzyme systems: The enzyme glucuronyl‑transferase, needed to conjugate (make water‑soluble) bilirubin, is low at birth and rises over the first 1‑2 weeks.
• Reduced enterohepatic circulation: In the first days, the newborn’s gut bacteria are limited, leading to more bilirubin being re‑absorbed from the intestines.
• Breast‑feeding factors: Suboptimal intake in the first 24‑48 hours (often called “breast‑feeding jaundice”) can increase bilirubin because of decreased stooling and dehydration.
• Prematurity: Pre‑term infants have even less mature hepatic function and a higher red‑cell mass, heightening risk.
• Blood‑type incompatibility (minor): While ABO or Rh incompatibility can cause pathologic jaundice, a mild, self‑limited rise in bilirubin may be seen in otherwise healthy babies.
• Genetic polymorphisms: Variants in the UGT1A1 gene can slightly lower enzyme activity, contributing to a higher bilirubin baseline.
• Maternal diabetes: Infants of diabetic mothers may have increased red‑cell mass and delayed liver maturation.
• Cesarean delivery or birth stress: Slightly higher hemolysis from delivery trauma can add to bilirubin load.
• Low caloric intake: Any cause of reduced feeding (e.g., poor latch, early discharge without support) can promote dehydration and slower bilirubin clearance.

Associated Symptoms

Physiologic jaundice is often an isolated finding, but some infants may show additional, usually mild, features:

• Yellowing that starts on the face and progresses downward to the chest, abdomen, and limbs.
• Normal temperature, heart rate, and respiratory rate for age.
• Good feeding behavior, though some may be slightly less enthusiastic in the first 24‑48 hours.
• Normal stool color (yellow‑brown) and urine output.
• Occasional “babies‑spitting” (spit‑up) due to immature gastro‑esophageal sphincter, not directly related to jaundice.

When to See a Doctor

Most cases of physiologic jaundice are benign, yet early evaluation is crucial to rule out pathologic causes and prevent complications. Contact a pediatrician or seek medical care if you notice any of the following:

• Yellowing that appears within the first 24 hours of life (suggests a pathologic process).
• Rapid progression—e.g., the jaundice spreads from the head to the chest and then the abdomen within a few hours.
• Jaundice persisting beyond 14 days in term infants or beyond 21 days in pre‑term infants.
• Skin appears yellow plus the whites of the eyes are not yet yellow (or vice‑versa) – this asymmetry may signal higher bilirubin levels.
• Feeding difficulties, lethargy, poor weight gain, or fewer wet diapers (< 6 per day).
• Any sign of illness: fever > 38 °C (100.4 °F), irritability, vomiting, or a rash.
• Family history of liver disease, G6PD deficiency, or previous infant with severe jaundice.

Diagnosis

Healthcare providers use a combination of visual assessment and laboratory testing to evaluate newborn jaundice:

1. Clinical Examination

• “Cephalocaudal” progression is noted (face → chest → abdomen → legs).
• Assessment of feeding adequacy (frequency of feeds, weight change).
• Observation for other warning signs (e.g., pallor, splenomegaly).

2. Bilirubin Measurements

• Transcutaneous bilirubinometer (TcB): A non‑invasive skin scanner that estimates bilirubin; useful for screening.
• Serum total bilirubin (TSB): A blood draw (heel stick) provides the definitive value. Levels are plotted on the AAP phototherapy guidelines based on age in hours, gestational age, and risk factors.

3. Additional Labs (if indicated)

• Blood type and Coombs test (to rule out hemolytic disease).
• G6PD level (especially in high‑risk ethnic groups).
• Complete blood count and reticulocyte count (to assess hemolysis).
• Liver function tests if a cholestatic process is suspected.

Treatment Options

Most infants with physiologic jaundice need only supportive care. Treatment decisions are guided by the serum bilirubin level, the infant’s age in hours, and any risk factors.

1. Enhanced Feeding

• Increase breast‑milk or formula intake to at least 8‑12 feedings per 24 hours. Frequent feeding stimulates bowel movements, helping eliminate bilirubin.
• For breastfeeding mothers, ensure proper latch and consider lactation consultation within the first 48 hours.
• If oral intake remains insufficient, temporary supplementation with expressed breast milk or formula is recommended.

2. Phototherapy

Phototherapy (light therapy) converts unconjugated bilirubin into water‑soluble isomers that can be eliminated without liver metabolism.

• Indicated when TSB exceeds the infant’s age‑specific phototherapy thresholds (see AAP nomogram).
• Types: conventional (fluorescent or LED) overhead lights, fiber‑optic blankets, or “bilirubin‑blanket” devices.
• Typical duration: 12–24 hours, reassessing TSB every 4–6 hours.

3. Exchange Transfusion

Rare for physiologic jaundice, but indicated when bilirubin rises rapidly into the “danger zone” (> 25 mg/dL in term infants) despite intensive phototherapy, or when signs of acute bilirubin encephalopathy appear.

4. Home Care Measures

• Expose the baby to indirect sunlight for short periods (10–15 minutes) while keeping the infant clothed and protected from overheating—this can modestly lower bilirubin, but should not replace medical treatment.
• Maintain a warm, comfortable environment; avoid excessive swaddling that may limit feeding cues.
• Track diaper output: ≥ 6 wet diapers and ≥ 3 yellow stools per day suggest adequate hydration.

Prevention Tips

While physiologic jaundice cannot be entirely prevented, several strategies reduce the likelihood of severe elevation:

• Early and frequent feeding: Initiate breast‑feeding within the first hour of life and continue every 2–3 hours.
• Effective lactation support: Hospital lactation consultants can help with latch, positioning, and milk supply.
• Monitor weight: Babies should regain birth weight by day 10‑12; delayed weight gain signals inadequate intake.
• Screen high‑risk infants: Pre‑term babies, infants of diabetic mothers, and those with known ABO/Rh incompatibility should have bilirubin checked before discharge.
• Avoid unnecessary vitamin K or antibiotic over‑use: These do not cause jaundice but can interfere with gut flora that aids bilirubin excretion.
• Educate caregivers: Provide written instructions on feeding frequency, signs of worsening jaundice, and when to call the pediatrician.

Emergency Warning Signs

Key Take‑aways

• Physiologic jaundice is common, usually harmless, and peaks between days 2‑4 of life.
• It stems from normal newborn physiology—high red‑cell turnover and immature liver function.
• Close monitoring, adequate feeding, and timely phototherapy prevent complications.
• Parents should seek medical advice if jaundice appears early, worsens quickly, or is accompanied by feeding problems, lethargy, or other concerning signs.

For further reading, consult reputable sources such as the Mayo Clinic, CDC, and the NIH NICHD.

```